1.      Aokage K, Suzuki K, Saji H, Wakabayashi M, Kataoka T, Sekino Y, Fukuda H, Endo M, Hattori A, Mimae T, Miyoshi T, Isaka M, Yoshioka H, Nakajima R, Nakagawa K, Okami J, Ito H, Kuroda H, Tsuboi M, Okumura N, Takahama M, Ohde Y, Aoki T, Tsutani Y, Okada M, Watanabe SI; Japan Clinical Oncology Group. Segmentectomy for ground-glass-dominant lung cancer with a tumour diameter of 3 cm or less including ground-glass opacity (JCOG1211): a multicentre, single-arm, confirmatory, phase 3 trial. Lancet Respir Med. 11(6):540-549, 2023.

2.     Chin K, Yamamoto S, Takahashi M, Kadowaki S, Kubota Y, Amanuma Y, Okada M, Kanda M, Kimura Y, Nogi Y, Arimitsu Y, Kitagawa Y. Effectiveness of taxanes following nivolumab in patients with advanced esophageal squamous cell carcinoma: a retrospective chart review of patients in ATTRACTION-3.Esophagus. 20(2):302-308,  2023.

3.     Fujiwara M, Mimae T, Tsutani Y, Miyata Y, Okada M. Complications and Survival After Lung Cancer Resection in Interstitial Lung Disease. Ann Thorac Surg. 115(3):701-708, 2023.

4.     Hamai Y, Emi M, Ibuki Y, Kurokawa T, Yoshikawa T, Ohsawa M, Hirohata R, Kitasaki N, Okada M. Ability of Blood Cell Parameters to Predict Clinical Outcomes of Nivolumab Monotherapy in Advanced Esophageal Squamous Cell Carcinoma. Onco Targets Ther. 16: 263-273, 2023.

5.     Handa Y, Ikeda T, Hanaki H, Miyata Y, Mukaida H, Okada M. Clinicopathologic study of stage I adenosquamous carcinoma of the lung. Jpn J Clin Oncol. 7;53(12):1201-1207,  2023.

6.     Handa Y, Tsutani Y, Mimae T, Miyata Y, Ito H, Shimada Y, Nakayama H, Ikeda N, Okada M. A multicenter propensity score-matched analysis of lymphadenectomy in N1-positve lung cancer. Jpn J Clin Oncol. 7;53(12):1183-1190, 2023.

7.     Hirano K, Hirohata R, Hamai Y, Yamaguchi S, Emi M, Yoshikawa T, Ohsawa M, Okada M. Esophageal Neuroendocrine Carcinoma With Pathological Complete Response After Neoadjuvant Chemotherapy Followed by Robot-assisted Surgery: A Case Report. Anticancer Res. 43(7):3289-3293, 2023.

8.     Hirohata R, Hamai Y, Murakami Y, Emi M, Nishibuchi I, Kurokawa T, Yoshikawa T, Ohsawa M, Kitasaki N, Okada M. Risk factors for aortoesophageal fistula in cT4b esophageal squamous cell carcinoma after definitive radiation therapy. J Thorac Dis. 15(10):5319-5329, 2023.

9.     Isaka T, Adachi H, Murakami K, Miura J, Kikunishi N, Shigeta N, Kudo Y, Miyata Y, Okada M, Ikeda N, Ito H. Preoperative predictors for recurrence sites associated with poor post-recurrence survival after surgery of non-small cell lung cancer: a multicenter study. BMC Cancer. 23(1):1064, 2023.

10.  Isaka T, Nagashima T, Adachi H, Narimatsu H, Murakami K, Shigefuku S, Kikunishi N, Shigeta N, Watabe K, Kudo Y, Miyata Y, Okada M, Ikeda N, Ito H. Wedge resection vs. segmentectomy for lung cancer measuring ≤ 2 cm with consolidation tumor ratio > 0.25.Front Oncol. 13:1253414, 2023.

11.   Ito M, Miyata Y, Kushitani K, Ueda D, Takeshima Y, Okada M. Distribution and prognostic impact of EGFR and KRAS mutations according to histological subtype and tumor invasion status in pTis-3N0M0 lung adenocarcinoma. BMC Cancer. 23(1):248, 2023.

12.  Ito M, Miyata Y, Okada M. Current clinical trials with non-coding RNA-based therapeutics in malignant diseases: A systematic review. Transl Oncol. 31:101634, 2023.

13.  Izaki Y, Amatya V J, Kambara T, Kushitani K, Miyata Y, Okada M, Takeshima Y. Musashi-1 Is a Novel Immunohistochemical Marker of Neuroendocrine Carcinoma of the Lung. Cancers. 15: 5631, 2023.

14.  Kagimoto A, Tsutani Y, Kushitani K, Kambara T, Mimae T, Miyata Y, Takeshima Y, Okada M. Usefulness of serum S100A4 and positron-emission tomography on lung cancer accompanied by interstitial pneumonia. Thorac Cancer. 14(4):381-388, 2023.

15.  Kamigaichi A, Aokage K, Ikeno T, Wakabayashi M, Miyoshi T, Tane K, Samejima J, Tsuboi M. Long-term survival outcomes after lobe-specific nodal dissection in patients with early non-small-cell lung cancer. Eur J Cardiothorac Surg. 63: ezad016, 2023.

16.  Kamigaichi A, Hamada A, Tsutani Y. Segmentectomy for patients with early-stage pure-solid non-small cell lung cancer. Front Oncol. 13:1287088, 2023.

17.  Kamigaichi A, Mimae T, Amioka J, Aoki G, Yoshimura K, Kawamoto N, Tsubokawa N, Miyata Y, Okada M. Segmentectomy preserves better immune-nutritional status than lobectomy in patients with early-stage lung cancer. Eur J Cardiothorac Surg. 63: ezad019, 2023.

18.  Kamigaichi A, Mimae T, Tsubokawa N, Miyata Y, Adachi H, Shimada Y, Ito H, Ikeda N, Okada M. Risk Factors for Recurrence of Stage I Epidermal Growth Factor Receptor Mutated Lung Adenocarcinoma. Ann Thorac Surg. S0003-4975(23):00089-9, 2023.

19.  Kamigaichi A, Mimae T, Tsubokawa N, Miyata Y, Adachi H, Shimada Y, Ito H, Ikeda N, Okada M. Segmentectomy for cancer control in radiologically pure-solid clinical stage IA3 lung cancer. Interdiscip Cardiovasc Thorac Surg. 37(3): ivad138, 2023.

20. Kamigaichi A, Mimae T, Tsubokawa N, Miyata Y, Adachi H, Shimada Y, Ito H, Ikeda N, Okada M. Wedge resection is an acceptable treatment option for radiologically low-grade lung cancer with solid predominance. Interdiscip Cardiovasc Thorac Surg. 36: ivac285, 2023.

21.  Kamigaichi A, Tsutani Y, Handa Y, Mimae T, Miyata Y, Okada M. Feasibility of repeated ipsilateral anatomical pulmonary resection. Surg Today. 53:379-385, 2023.

22. Kato K, Doki Y, Ogata T, Motoyama S, Kawakami H, Ueno M, Kojima T, Shirakawa Y, Okada M, Ishihara R, Kubota Y, Amaya-Chanaga C, Chen T, Matsumura Y, Kitagawa Y. First-line nivolumab plus ipilimumab or chemotherapy versus chemotherapy alone in advanced esophageal squamous cell carcinoma: a Japanese subgroup analysis of open-label, phase 3 trial (CheckMate 648/ONO-4538-50). Esophagus. 20(2):291-301, 2023.

23. Kawamoto N, Tsutani Y, Kamigaichi A, Ohsawa M, Mimae T, Miyata Y, Okada M. Tumour location predicts occult N1 nodal metastasis in clinical stage I non-small-cell lung cancer. Eur J Cardiothorac Surg. 63(2):ezac575, 2023.

24. Kawamoto N, Tsutani Y, Okada M. Reply to Sanz-Santos et al. Eur J Cardiothorac Surg. 63(3):ezad084, 2023.

25. Khairunnisa NI, Yamasaki F, Miyata Y, Okada M, Horie N. The Efficacy of PCSK9 Inhibitors in Treating Hypercholesterolemia Caused by Lorlatinib : A Report of Two Cases. Clin Lung Cancer. 24(5): e176-e178, 2023.

26. Kimura Y, Sasada S, Emi A, Masumoto N, Kadoya T, Arihiro K, Okada M. 18F-fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Predicts Tumor Immune Microenvironment Function in Early Triple-negative Breast Cancer. Anticancer Res. 43: 127-136, 2023.

27. Maniwa T, Okami J, Miyoshi T, Wakabayashi M, Yoshioka H, Mimae T, Endo M, Hattori A, Nakagawa K, Isaka T, Isaka M, Kita R, Sekino Y, Mitome N, Aokage K, Saji H, Nakajima R, Okada M, Tsuboi M, Asamura H, Fukuda H, Watanabe SI; West Japan Oncology Group and Japan Clinical Oncology Group. Lymph node dissection in small peripheral lung cancer: Supplemental analysis of JCOG0802/WJOG4607L. J Thorac Cardiovasc Surg.S0022-5223(23):01099-1, 2023.

28. Mimae T, Okada M. Asian Perspective on Lung Cancer Screening. Thorac Surg Clin. 33(4):385-400, 2023.

29. Mimae T, Okada M. [Dawn of Radical Segmentectomy for Small Sized Peripheral Non-small Cell Lung Cancer]. Kyobu Geka. 76(1):4-8, 2023.

30. Mimae T, Saji H, Nakamura H, Okumura N, Tsuchida M, Sonobe M, Miyazaki T, Aokage K, Nakao M, Haruki T, Okada M, Suzuki K, Yoshino I. Sublobar Resection for Non-Small Cell Lung Cancer in Octogenarians: A Prospective, Multicenter Study. Ann Thorac Surg. 116(3):543-551, 2023.

31.  Minatoya K, Sato Y, Toh Y, Abe T, Endo S, Hirata Y, Ishida M, Iwata H, Kamei T, Kawaharada N, Kawamoto S, Kohno K, Kumamaru H, Matsumiya G, Motomura N, Nakahara R, Okada M, Saji H, Saito A, Shimizu H, Suzuki K, Takemura H, Taketani T, Takeuchi H, Tatsuishi W, Yamamoto H, Yasuda T, Watanabe M, Yoshimura N, Tsuchida M, Sawa Y. Thoracic and cardiovascular surgeries in Japan during 2019 : Annual report by the Japanese Association for Thoracic Surgery. Committee for Scientific Affairs, The Japanese Association for Thoracic Surgery; Gen Thorac Cardiovasc Surg. 71(10):595-628, 2023.

32. Miyoshi S, Nishibuchi I, Murakami Y, Katsuta T, Imano N, Hirokawa J, Hamai Y, Emi M, Okada M, Nagata Y. Long-term results of chemoradiotherapy with elective nodal irradiation for resectable locally advanced esophageal cancer in three-dimensional planning system. Int J Clin Oncol. 28: 382-391, 2023.

33. Miyoshi T, Ito H, Wakabayashi M, Hashimoto T, Sekino Y, Suzuki K, Tsuboi M, Moriya Y, Yoshino I, Isaka T, Hattori A, Mimae T, Isaka M, Maniwa T, Endo M, Yoshioka H, Nakagawa K, Nakajima R, Tsutani Y, Saji H, Okada M, Aokage K, Fukuda H, Watanabe SI. Risk factors for loss of pulmonary function after wedge resection for peripheral ground-glass opacity dominant lung cancer. Eur J Cardiothorac Surg. 64(6):ezad365, 2023.

34. Ogiya A, Nagura N, Shimo A, Nogi H, Narui K, Seki H, Mori H, Sasada S, Ishitobi M, Kondo N, Yamauchi C, Akazawa K, Shien T; Collaborative Study Group of Scientific Research of the Japanese Breast Cancer Society. Long-Term Outcomes of Breast Cancer Patients with Local Recurrence After Mastectomy Undergoing Immediate Breast Reconstruction: A Retrospective Multi-institutional Study of 4153 Cases. Ann Surg Oncol 30: 6532-6540, 2023.

35. Ohsawa M, Hamai Y, Emi M, Ibuki Y, Kurokawa T, Yoshikawa T, Hirohata R, Kitasaki N, Okada M. Real-world clinical outcomes of nivolumab and taxane as a second- or later-line therapy for recurrent or unresectable advanced esophageal squamous cell carcinoma. Front Oncol. 13:1126536, 2023.

36. Ohsawa M, Hamai Y, Emi M, Ibuki Y, Kurokawa T, Yoshikawa T, Hirohata R, Kitasaki N, Okada M. The treatment efficacy and prognosis of each treatment in early postoperative recurrence of esophageal squamous cell carcinoma. Surg Today. 54(1):53-63, 2023.

37. Okada M, Mimae T, Miyata Y. Segmentectomy and Wedge Resection Should Be Distinguished as Sublobar Resections for Lung Cancer. Ann Thorac Surg. 116(4):859, 2023.

38. Saito Y, Hamamoto Y, Hirata K, Yamasaki M, Watanabe M, Abe T, Tsubosa Y, Hamai Y, Murakami K, Bamba T, Yoshii T, Tsuda M, Watanabe M, Ueno M, Kitagawa Y. Real-world management and outcomes of older patients with locally advanced esophageal squamous cell carcinoma: a multicenter retrospective study. BMC Cancer. 23: 283, 2023.

39. Sasada S, Kondo N, Hashimoto H, Takahashi Y, Terata K, Kida K, Sagara Y, Ueno T, Anan K, Suto A, Kanbayashi C, Takahashi M, Nakamura R, Ishiba T, Tsuneizumi M, Nishimura S, Naito Y, Hara F, Shien T, Iwata H. Prognostic impact of adjuvant endocrine therapy for estrogen receptor-positive and HER2-negative T1a/bN0M0 breast cancer. Breast Cancer Res Treat 202: 473-483, 2023.

40. Shimada Y, Yoshioka Y, Kudo Y, Mimae T, Miyata Y, Adachi H, Ito H, Okada M, Ohira T, Matsubayashi J, Ochiya T, Ikeda N. Extracellular vesicle-associated microRNA signatures related to lymphovascular invasion in early-stage lung adenocarcinoma. Ann Thorac Surg. Sci Rep. 13(1):4823, 2023.

41.  Shimoji K, Nakashima T, Masuda T, Namba M, Sakamoto S, Yamaguchi K, Horimasu Y, Mimae T, Miyamoto S, Iwamoto H, Fujitaka K, Hamada H, Okada M, Hattori N. Hypoxia-inducible factor 1α modulates interstitial pneumonia-mediated lung cancer progression. J Transl Med. 21(1):857, 2023.

42. Sugawara S, Tanaka K, Imamura F, Yamamoto N, Nishio M, Okishio K, Hirashima T, Tanaka H, Fukuhara T, Nakahara Y, Kurata T, Katakami N, Okada M, Horinouchi H, Udagawa H, Kasahara K, Satouchi M, Saka H, Tokito T, Hosomi Y, Aoe K, Kishi K, Ohashi K, Yokoyama T, Adachi N, Noguchi K, Schwarzenberger P, Kato T.  Pembrolizumab plus chemotherapy in Japanese patients with metastatic squamous non-small-cell lung cancer in KEYNOTE-407. Cancer Sci. 114(8):3330-3341, 2023.

43. Suzuki K, Sasada S, Nishi H, Kimura Y, Shintani T, Emi A, Masumoto N, Kadoya T, Kawaguchi H, Okada M. Impact of oral hygiene on febrile neutropenia during breast cancer chemotherapy. Breast Cancer 30: 151-155, 2023.

44. Takamochi K, Haruki T, Oh S, Endo M, Funai K, Kitamura Y, Tsuboi M, Tsukioka T, Suzuki H, Ito H, Okumura N, Ueno T, Ikeda N, Iwata H, Okada M, Ichikawa T, Okamoto T, Nojiri S, Suzuki K; Advanced Clinical Trial Chest Surgery Group. Early chest tube removal regardless of drainage volume after anatomic pulmonary resection: A multicenter, randomized, controlled trial. J Thorac Cardiovasc Surg. S0022-5223(23):01007-3, 2023.

45. Takei H, Kunitoh H, Wakabayashi M, Kataoka T, Sekino Y, Mizutani T, Tsuboi M, Ikeda N, Asamura H, Okada M, Takahama M, Ohde Y, Okami J, Shiono S, Aokage K, Watanabe SI; Prospective, Multi-Institutional Observational Study of Deterioration in Activities of Daily Living in Elderly Patients After Lung Cancer Surgery. Lung Cancer Surgical Study Group of the Japan Clinical Oncology Group, Japan. JTO Clin Res Rep. 4(8):100550, 2023.

46. Tanaka Y, Maniwa Y, Sugio K, Okamoto T, Nibu KI, Omori T, Endo S, Kuwano H, Chida M, Toh Y, Okada M, Shiotani A, Yoshino I. The efficacy of thoracoscopic surgery for descending necrotizing mediastinitis. Interdiscip Cardiovasc Thorac Surg. 36(4):ivad053,  2023.

47. Tanizaki J, Kuroda H, Yokoyama T, Takahama M, Shoda H, Nakamura A, Kitamura Y, Mamesaya N, Kadota Y, Sawa K, Okishio K, Okada M, Suminaka C, Noda K, Sakai K, Chiba Y, Nishio K, Chamoto K, Honjo T, Yamamoto N, Nakagawa K, Hayashi H. Lack of Association of Plasma Levels of Soluble Programmed Cell Death Protein 1, Programmed Death-Ligand 1, and CTLA-4 With Survival for Stage II to IIIA NSCLC After Complete Resection and Adjuvant Chemotherapy. JTO Clin Res Rep. 4(12):100590, 2023.

48. Terada M, Ito A, Kikawa Y, Koizumi K, Naito Y, Shimoi T, Ishihara M, Yamanaka T, Ozaki Y, Hara F, Nakamura R, Hattori M, Miyashita M, Kondo N, Yoshinami T, Takada M, Matsumoto K, Narui K, Sasada S, Iwamoto T, Hosoda M, Takano Y, Oba T, Sakai H, Murakami A, Higuchi T, Tsuchida J, Tanabe Y, Shigechi T, Tokuda E, Harao M, Kashiwagi S, Mase J, Watanabe J, Nagai SE, Yamauchi C, Yamamoto Y, Iwata H, Saji S, Toyama T. The Japanese Breast Cancer Society Clinical Practice Guidelines for systemic treatment of breast cancer, 2022 edition. Breast Cancer. 30: 872-884, 2023.

49. Tokumo K, Masuda T, Nakashima T, Namba M, Yamaguchi K, Sakamoto S, Horimasu Y, Miyamoto S, Iwamoto H, Fujitaka K, Miyata Y, Okada M, Hamada H, Hattori N. Association between Plasminogen Activator Inhibitor-1 and Osimertinib Tolerance in EGFR-Mutated Lung Cancer via Epithelial-Mesenchymal Transition. Cancers (Basel). 15(4):1092, 2023.

50. Tomoshige K, Stuart WD, Fink-Baldauf IM, Ito M, Tsuchiya T, Nagayasu T, Yamatsuji T, Okada M, Fukazawa T, Guo M, Maeda Y. FOXA2 Cooperates with Mutant KRAS to Drive Invasive Mucinous Adenocarcinoma of the Lung. Cancer Res. 83(9):1443-1458, 2023.

51.  Tsubokawa N, Mimura T, Tadokoro K, Yamashita Y. Risk factors for long-term decline in post-operative pulmonary function after lung resection. Jpn J Clin Oncol. 53(3):245-252, 2023.

52. Tsubokawa N, Mimura T, Tadokoro K, Yamashita Y. Successful conservative treatment for massive tracheal necrosis after lung segmentectomy. Surg Case Rep. 9(1):160, 2023.

53. Ueda D, Tsutani Y, Okada M. Reply to Zhou and Yu. Eur J Cardiothorac Surg.  63(6):ezad195, 2023.

54. Yamaguchi A, Ishitobi M, Nagura N, Shimo A, Seki H, Ogiya A, Sakurai T, Seto Y, Oshiro C, Sasada S, Kato M, Kawate T, Kondo N, Narui K, Nakagawa T, Nogi H, Yamauchi C, Tsugawa K, Kajiura Y, Shien T. Classification of Local Recurrence After Nipple-Sparing Mastectomy Based on Location: The Features of Nipple-Areolar Recurrence Differ from Those of Other Local Recurrences. Ann Surg Oncol. 30: 1678-1686, 2023.

55. Yamakado R, Ishitobi M, Kondo N, Yamauchi C, Sasada S, Nogi H, Saiga M, Ogiya A, Narui K, Seki H, Nagura N, Shimo A, Sakurai T, Niikura N, Mori H, Shien T; Collaborative Study Group of Scientific Research of the Japanese Breast Cancer Society. Physicians' perception about the impact of breast reconstruction on patient prognosis: a survey in Japan. Breast Cancer. 30: 302-308, 2023.

56. Yoshino I, Moriya Y, Suzuki K, Wakabayashi M, Saji H, Aokage K, Suzuki M, Ito H, Matsumoto I, Kobayashi M, Okamoto T, Okada M, Yamashita M, Ikeda N, Nakamura S, Kataoka T, Tsuboi M, Watanabe SI; West Japan Oncology Group and Japan Clinical Oncology Group. Long-term outcome of patients with peripheral ground-glass opacity-dominant lung cancer after sublobar resections. J Thorac Cardiovasc Surg. 166(4):1222-1231. e1, 2023.

57. 見前隆洋，岡田守人．末梢小型非小細胞肺癌に対する根治的区域切除の幕開け．胸部外科．76：4-8，2023．

58. 笹田伸介，近藤直人，石飛真人，野木裕子，山内智香子，森弘樹，荻谷朗子，成井一隆，名倉直美，志茂彩華，関大仁，櫻井照久，寺田かおり，雜賀美帆，枝園忠彦．乳癌術後乳房再建の現状と課題　―第26回日本乳癌学会班研究「乳房再建の安全性と予後に関する研究」全国アンケート調査―．乳癌の臨床．38：325-335，2023.

59. 甲斐あずさ，舛本法生，藤本睦，鈴木江梨，小林美恵，笹田伸介，惠美純子，角舎学行，佐々木彩乃，永松将吾，岡田守人．乳癌に対する人工物を用いた一次乳房再建の術後合併症に関する検討. 乳癌の臨床．38(3)：213-218，2023．